Skip to main content
. 2014 Mar 21;7:45–55. doi: 10.2147/JIR.S54360

Table 2.

Stress test results in all study subjects and divided in non-CAD and CAD50 subjects

All subjects n=155 Non-CAD n=114 CAD50 n=41 P-value
Pretest probability, % ± SD 37.0±25.2 28.1±19.5 61.7±22.8 <0.0001
Stress test performance
 Duration, minutes ± SD 9.3±3.7 9.3±3.7 9.3±3.4 NS
 Maximum workload, METS ± SD 8.4±2.9 8.9±3.0 7.2±1.9 0.001
 Peak HR, beats/minute ± SD 149.3±22.1 152.6±22.0 140.1±19.9 0.002
 % of max predicted HR, % ± SD 92.0±11.2 92.6±11.2 90.5±11.3 NS
 Subjects reaching 85% of max predicted HR, n (%) 123 (79.4) 93 (81.6) 30 (73.2) NS
 Peak SBP, mmHg ± SD 193.8±30.9 192.7±30.9 196.9±28.4 NS
Reason for termination of test
 Exhaustion, n (%) 104 (67.1) 76 (66.7) 28 (68.3) NS
 Angina, n (%) 4 (2.6) 0 (0) 4 (9.8) <0.001
 Muscular weakness, n (%) 23 (14.8) 18 (15.8) 5 (12.2) NS
 Dyspnea, n (%) 20 (12.9) 17 (14.9) 3 (7.3) NS
 Arrhythmia, n (%) 4 (2.6) 3 (2.6) 1 (2.4) NS
Angina <0.0001
 No, n (%) 127 (81.9) 103 (90.4) 24 (58.5)
 Nonlimiting, n (%) 24 (15.5) 11 (9.7) 13 (31.7)
 Limiting, n (%) 4 (2.6) 0 (0.0) 4 (9.8)
ST depression (mV) 0.10
 0.0, n (%) 114 (73.6) 88 (77.2) 26 (63.4)
 ≥1.0, n (%) 41 (26.5) 26 (22.8) 15 (36.6)
Conclusion of the ET 0.04
 Conclusive negative ET, n (%) 88 (56.1) 71 (61.2) 17 (41.5)
 Inconclusive ET, n (%) 22 (14.2) 16 (14.0) 6 (14.6)
 Positive ET, n (%) 45 (28.7) 27 (23.3) 18 (43.9)
ET protocol used <0.001
 25 watts/25 watts/2 minutes, n (%) 119 (76.8) 79 (69.3) 40 (97.6)
 50 watts/50 watts/2 minutes, n (%) 36 (23.2) 35 (30.7) 1 (2.4)

Notes: Data are presented as mean ± SD, or n (%). CAD50 refers to subjects with ≥50% coronary artery lumen diameter stenosis.

Abbreviations: CAD, coronary artery disease; SD, standard deviation; MET, metabolic equivalent; HR, heart rate; SBP, systolic blood pressure at rest; ET, exercise test.